Skip to content
Steady
Get Steady
ResearchDoctor
DoctorCommunicationWegovy

How to make your GLP-1 doctor's visit actually useful

Ten minutes goes fast. Most women leave the appointment without having asked the questions that would have changed the next three months. Here is the worksheet to walk in with.

Published May 20, 20265 min read
2 primary sources citedReviewed by Steady editorial team

The 30-second summary

  • GLP-1 appointments are usually 10–15 minutes. Without preparation, most of that time goes to refills and small talk.
  • The questions that actually matter cluster around five areas: rate of loss, side effects, dose strategy, lab work, and next steps.
  • Bring a one-page summary. Leave with a clear plan for the next three months.

What goes wrong in a typical appointment

A common pattern, observed across hundreds of women: arrive feeling unsure of how things are going, get asked "How are you feeling?", reply "Good, I think," receive a refill, walk out, realise on the drive home what you wanted to ask.

The shape of the appointment is determined by who shows up most prepared. Without preparation, the appointment defaults to whatever the prescriber prioritises, which is usually safety screening and prescription continuity. Both important. Neither is the strategic conversation about your specific journey.

A 10-minute conversation can do a lot if it is the right 10 minutes.

The one-page summary to bring

Write or print a single page with these sections. Update before each appointment.

My numbers

  • Starting weight: [date and number]
  • Current weight: [today's number]
  • Trend: average pace over the last 4 weeks
  • Lowest recent weight: [if relevant]

My medication

  • Drug and brand: Wegovy / Mounjaro / Zepbound / etc.
  • Current dose: in mg, weekly
  • Date of last dose change: [date]
  • Adherence: doses taken vs missed in the last 12 weeks

My side effects

  • Currently active: what is bothering you this week
  • Pattern over the last 4 weeks: what has been worst, what is improving
  • Severe events, if any: any episodes that worried you

My questions for today

  • Three questions, written down. The questions you most want answered.

This page should fit on one side of A4 or US Letter. It should take five minutes to update. It is the most useful thing you can bring.

The five questions worth asking

In rough order of importance.

1. Are we losing weight at the right pace?

The honest answer for many women: too fast. If you are losing more than 1% of body weight per week, the rate is in the territory that drives the cosmetic, muscle, and skin concerns covered elsewhere in this hub.

The question: "My weekly loss is averaging X. Is that the right rate for me, or should we be slowing down?"

This is the question most prescribers will not raise unprompted. They are looking for "are you losing enough?" not "are you losing too much?"

2. Should we pause the titration, or move up?

The default protocol moves you up the dose every four weeks. As covered in our titration article, this is a maximum cadence, not a requirement.

The question: "If side effects are still active, or if my current rate of loss is faster than we want, should we stay at this dose for another cycle?"

A reasonable answer from a prescriber is "yes, that's fine." If the answer is "we should always climb on schedule," that deserves a follow-up about why.

3. What labs would be useful?

A baseline-plus-follow-up metabolic panel often changes the picture meaningfully. Useful tests at the start, at 3 months, and at 6 months:

  • HbA1c (especially if prediabetes or diabetes)
  • Fasting glucose and insulin
  • Lipid panel
  • Liver function (ALT, AST)
  • Vitamin D, particularly if you live in a temperate climate
  • Ferritin (iron stores), particularly if fatigue is significant
  • TSH (thyroid), if fatigue or mood symptoms

You do not need all of these every time. A baseline at the start and a follow-up at 6 months is a reasonable cadence. The question: "Are there any labs you would recommend now to track how I'm responding?"

4. What's the plan if [scenario]?

A short list of contingency conversations worth having:

  • "If my weight plateaus for 6 weeks, what's the move? Move up, stay, or switch?"
  • "If a side effect becomes intolerable, what's the protocol?"
  • "If I want to come off the drug eventually, what's the maintenance plan?"
  • "If I become pregnant unintentionally, what's the protocol?"

Each of these has a clean answer that most prescribers will give if asked. Without asking, you arrive at the situation without a plan.

5. What can I do between now and the next visit?

Most appointments end with a refill. The conversation worth adding: "What are the two or three things I can do well between now and our next visit that would improve the next conversation?"

Common answers: tighten protein intake, add resistance training, get a sleep study if symptoms suggest, track symptoms more carefully, schedule the labs.

What not to ask

A short list of questions that are common and unhelpful:

  • "Is it normal that...?" Almost everything is normal. The useful question is whether it is workable.
  • "How much weight will I lose?" The honest answer is unknowable. The trial average is not your average.
  • "Is there a better drug?" A more useful version: "Given my response so far, is there a reason to consider switching?"

After the appointment

Spend five minutes immediately after the visit writing down what was said. Specifically:

  • The plan for the next 3 months
  • Any tests or follow-ups to schedule
  • What was decided about dose
  • The next appointment date

Memory degrades fast. Notes hold.

What Steady does with this

Steady's "appointment summary" export pulls the last 3 months of weight, dose, symptoms, and labs into a one-page PDF designed to be shared with a prescriber. It saves the 30 minutes of trying to remember and the awkward summary-from-scratch at the start of the visit. The point is to make the data conversation effortless so the strategic conversation has time to happen.

Sources

  1. American Medical Association. Tips for effective doctor-patient communication. AMA
  2. Cordasco KM. Obtaining informed consent from patients. J Gen Intern Med 2013. PubMed

Medical disclaimer: The questions and templates here are general. Your specific clinical situation belongs with your prescriber. See our full medical disclaimer.

Reviewed by Steady editorial team.
Last updated 2026-05-20.
Keep reading